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he eukaryotic translation initiation factor eIF4E is
a critical modulator of cellular growth with functions
in the nucleus and cytoplasm. In the cytoplasm,
recognition of the 5
 
 
 
 m
 
7
 
G cap moiety on all mRNAs is
sufﬁcient for their functional interaction with eIF4E. In
contrast, we have shown that in the nucleus eIF4E asso-
ciates and promotes the nuclear export of cyclin D1, but
not GAPDH or actin mRNAs. We determined that the
basis of this discriminatory interaction is an 
 
 
 
100-nt se-
quence in the 3
 
 
 
 untranslated region (UTR) of cyclin D1
mRNA, we refer to as an eIF4E
 
 
 
sensitivity element (4E-SE).
T
 
We found that cyclin D1 mRNA is enriched at eIF4E nu-
clear bodies, suggesting these are functional sites for
organization of speciﬁc ribonucleoproteins. The 4E-SE
is required for eIF4E to efﬁciently transform cells,
thereby linking recognition of this element to eIF4E medi-
ated oncogenic transformation. Our studies demonstrate
previously uncharacterized fundamental differences in
eIF4E-mRNA recognition between the nuclear and cyto-
plasmic compartments and further a novel level of regu-
lation of cellular proliferation.
 
Introduction
 
The eukaryotic translation initiation factor eIF4E is involved in
modulation of cellular growth. Moderate overexpression of
eIF4E leads to dysregulated growth and malignant transforma-
tion (Lazaris-Karatzas et al., 1990). The levels of eIF4E are el-
evated in several human malignancies including a subset of
myeloid leukemias and breast cancer (Nathan et al., 1997;
Topisirovic et al., 2003b). Importantly, both the nuclear and
cytoplasmic functions of eIF4E contribute to its ability to trans-
form cells (Sonenberg and Gingras, 1998; Strudwick and Borden,
2002). In the cytoplasm, eIF4E is required for cap-dependent
translation, a process highly conserved from yeast to humans
(Sonenberg and Gingras, 1998). Here, eIF4E binds the methyl
7-guanosine (m
 
7
 
G) cap moiety present on the 5
 
 
 
 end of mRNAs
and subsequently recruits the given mRNA to the ribosome
(Sonenberg and Gingras, 1998).
In the nucleus, eIF4E functions to promote export from
the nucleus to the cytoplasm of at least two reported mRNAs,
cyclin D1 and ornithine decarboxylase (ODC), but does not
alter GAPDH or actin mRNA export (Rousseau et al., 1996;
Lai and Borden, 2000; Cohen et al., 2001; Topisirovic et al.,
2002, 2003a). Since the first report of the nuclear localization
of eIF4E 12 yr ago (Lejbkowicz et al., 1992), studies showed
that up to 68% of cellular eIF4E is in the nucleus (Iborra et
al., 2001), where it associates with nuclear bodies in a wide
variety of organisms including yeast (Lang et al., 1994),
 
Drosophila
 
 (Cohen et al., 2001), 
 
Xenopus
 
 (Strudwick and
Borden, 2002), and humans (Cohen et al., 2001; Iborra et al.,
2001; Topisirovic et al., 2003b). These bodies are found in all
cell types reported including nearly 30 cell lines and primary
cells from diverse lineages such as NIH3T3, HEK293T,
U2OS, K562, and U937 (this paper; Lejbkowicz et al., 1992;
Lai and Borden, 2000; Cohen et al., 2001; Strudwick and Bor-
den, 2002; Topisirovic et al., 2002, 2003a). In mammalian
cells, a large subset of eIF4E nuclear bodies coincides with
those associated with the promyelocytic leukemia protein
PML (Lai and Borden, 2000; Cohen et al., 2001; Topisirovic
et al., 2003a,b). PML was the first identified regulator of
eIF4E-dependent mRNA export (Cohen et al., 2001). The
RING domain of PML directly binds the dorsal surface of
eIF4E, reducing its affinity for the m
 
7
 
G cap by 
 
 
 
100-fold
(Cohen et al., 2001; Kentsis et al., 2001). This loss of cap-
binding activity correlates with a loss of the mRNA export
function and loss of transformation activity of (Cohen et al.,
2001; Topisirovic et al., 2002, 2003a).
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There is evidence that the mRNA export function of
eIF4E is linked to its oncogenic transformation activity. In a
subset of primary human myeloid leukemia specimens, eIF4E-
dependent cyclin D1 mRNA export is substantially up-regu-
lated (Topisirovic et al., 2003b). Additionally, a mutant form of
eIF4E, W73A, enters the nucleus colocalizing with endoge-
nous eIF4E nuclear bodies, enhances the transport of cyclin D1
mRNAs to the cytoplasm and subsequently transforms immor-
talized cells (see Fig. 3, A and E; this paper; Cohen et al., 2001;
Topisirovic et al., 2003a). This occurs despite the fact that
W73A eIF4E cannot bind eIF4G and thus cannot act in transla-
tion (Sonenberg and Gingras, 1998).
Observations made by our group and the Sonenberg labo-
ratory that eIF4E functionally discriminates between cyclin D1
and GAPDH mRNAs are surprising because the traditional
view is that eIF4E binds the m
 
7
 
G cap found on all mRNAs re-
gardless of other sequence specific features. Thus, this func-
tional discrimination presents a conundrum in terms of our un-
derstanding of eIF4E mRNA recognition in the nucleus. We
explore the possibility that in the nucleus, eIF4E recognition of
mRNA is fundamentally different than in the cytoplasm. Here,
we identify a 100-nt sequence from the cyclin D1 3
 
 
 
UTR
which sensitizes this mRNA to eIF4E in the nucleus and is in-
volved in eIF4E mediated cell transformation.
 
Results
 
eIF4E physically associates with cyclin 
D1 mRNAs in the nucleus
 
To understand the underlying basis for the specificity of
eIF4E’s effects on promotion of mRNA export, we examined
the novel possibility that eIF4E physically associated only with
specific mRNAs in the nucleus. In this way, eIF4E-dependent
promotion of export of cyclin D1 mRNAs could arise through a
specific physical interaction of this mRNA with eIF4E in the
nucleus. First, we examined whether eIF4E immunoprecipi-
tates with cyclin D1 or housekeeping genes like GAPDH and
actin mRNAs in total cell lysates and subsequently in nuclear
and cytoplasmic fractions in a variety of cell lines including
U2OS, NIH3T3, K562, U937, and HEK293T cells. Results
were the same across cell lines so only representative results
are shown here (Fig. 1). Note that both the mRNAs, and the
eIF4E examined here, are endogenous. RNAs were detected
for each experiment independently using multiple PCR strate-
gies including quantitative RT-PCR and semi-quantitative PCR.
Consistent results were always obtained using these different
methodologies.
Immunoprecipitation studies indicated that in total cell ly-
sates, eIF4E bound both cyclin D1 and GAPDH mRNAs, as ex-
pected because these mRNAs are capped (Fig. 1 A). In the
nuclear fraction, eIF4E physically associates with a readily de-
tectable fraction of cyclin D1 mRNA (Fig. 1 B). Yet, no detect-
able association between eIF4E and GAPDH mRNA or actin
mRNA is observed in the nuclear fraction in contrast to total cell
lysates or the cytoplasmic fractions (Fig. 1 A and not depicted).
These results are confirmed by our semi-quantitative and inde-
pendently RT-PCR analysis (Fig. 1, B, D, and E). Also, eIF4E
associates only with processed cyclin D1 mRNAs in the nucleus,
as observed using specific primers and RT-PCR (not depicted).
Importantly, the ability of eIF4E to associate with
GAPDH or cyclin D1 mRNAs was monitored using material
from the same eIF4E immunoprecipitations. Thus, differences
in binding affinity between GAPDH and cyclin D1 are not a re-
sult of differences in immunoprecipitation efficiency or in the
quality of the fractionation between experiments. Controls for
the quality of these immunoprecipitations and fractionations
are given below and discussed in the Materials and methods.
The above findings suggested that eIF4E-mRNA recog-
nition in the nucleus could be substantially different to that in
the cytoplasm. In particular, it was critical to establish the im-
portance of cap binding for eIF4E-mRNA recognition in the
nucleus. Thus, we examined which features of eIF4E were re-
quired for interaction with cyclin D1 mRNA in the nuclear
fraction using the GST pull-down approach referred to as spe-
cific nucleic acids associated with protein (SNAAP; Trifillis
et al., 1999). Here nuclear lysates were incubated with glu-
tathione sepharose-bound wild-type or mutant forms of eIF4E-
GST or GST (Fig. 1 C). Consistent with the immunoprecipita-
tion findings, wild-type eIF4E associates with cyclin D1 but
not GAPDH mRNAs. No association is observed with GST
(Fig. 1 C) or an unrelated mRNA-binding protein 
 
 
 
CP1-GST
(not depicted) for either mRNA. The W56A eIF4E mutant,
which does not bind the cap, does not bind cyclin D1 indicating
that eIF4E still requires its cap-binding activity to associate
with mRNAs in the nuclear fraction (Fig. 1 C). We extended
these studies to test whether the dorsal surface mutant, W73A,
can still associate with cyclin D1 mRNA in the nucleus, be-
cause this mutant readily enhances transport of cyclin D1
when expressed (Topisirovic et al., 2002, 2003a). Importantly,
W73A mutant is deficient in translation but not transport
(Sonenberg and Gingras, 1998; Cohen et al., 2001; Topisirovic
et al., 2002, 2003a). This mutation does not detectably reduce
binding to cyclin D1 mRNA as compared with wild type (Fig.
1 C). Note that previous biophysical studies indicate that
W56A and W73A mutants have structures indistinguishable
from wild-type eIF4E (Kentsis et al., 2001). Thus, there ap-
pears to be a correlation between the ability of eIF4E to physi-
cally associate with cyclin D1 mRNA in the nucleus and the
ability of eIF4E to enhance transport of these mRNAs.
We extended these findings to further demonstrate the re-
quirement for the m
 
7
 
G cap for association of mRNA with
eIF4E in the nucleus (Fig. 1, D and E). We monitored the abil-
ity of m
 
7
 
G cap analogue (m
 
7
 
GpppG) to compete for mRNA
binding using semi-quantitative PCR and independently, quan-
titative RT-PCR methods. Consistent with the above results us-
ing the W56A mutant, the cap analogue successfully disrupts
the association of cyclin D1 mRNAs with eIF4E. In contrast,
GpppG, which does not bind eIF4E, does not disrupt its associ-
ation with cyclin D1. In either case eIF4E does not associate
with GAPDH mRNA. Together, these findings indicate that
eIF4E requires the m
 
7
 
G cap in order to associate with specific
mRNAs in the nucleus. Note that treatment with m
 
7
 
GpppG or
GpppG did not alter the amount of eIF4E immunoprecipitated
by eIF4E antibody in these reactions (unpublished data). 
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Interestingly, when the cytoplasmic fractions of cells were
incubated with eIF4E-GST, all mRNAs bound, similar to the re-
sults we observed for immunoprecipitation experiments using the
total lysates or cytoplasmic fraction (unpublished data). It is of
interest that even when nuclear lysates are incubated with recom-
binant eIF4E in the SNAAP assay, we do not observe an associa-
tion with GAPDH mRNA (Fig. 1 C). This raises the possibility
that eIF4E-mRNA recognition is restricted in nuclear lysates by
other regulatory elements that are not present in the cytoplasm,
where cap binding is sufficient to mediate these interactions.
As a positive control, we extended our experiments to de-
termine whether both GAPDH and cyclin D1 mRNA bound to
the other nuclear cap-binding proteins, CBP 80 and CBP 20
which together form the cap-binding complex (CBC). In gen-
eral, CBC associates with all transcripts cotranscriptionally
(Visa et al., 1996). Immunoprecipitations were performed us-
ing an antibody to CBP 80. Results were monitored by semi-
quantitative and independently by RT-PCR methods. Parallel
experiments were performed with eIF4E antibodies using the
same nuclear fractions. As expected, CBC associates with both
cyclin D1 and GAPDH transcripts, whereas eIF4E associates
only with cyclin D1 mRNA (Fig. 1 F). We further determined
whether the CBC associates with eIF4E. Using immunoprecip-
itation (Fig. 1 G) and separately immunofluorescence (not de-
picted), we observed no association between the CBC and
eIF4E. These findings are consistent with previous reports
showing no coimmunoprecipitation between CBC and eIF4E
(Ishigaki et al., 2001; Lejeune et al., 2002). However, we can-
not rule out the possibility of a transient interaction between
the CBC and eIF4E that we cannot detect by these methods.
Together, these data suggest that eIF4E–cyclin D1 mRNA and
CBC–cyclin D1 mRNA complexes are distinct complexes in
the nucleus.
We cannot rule out the possibility that, in the nucleus,
eIF4E binds a low level of GAPDH mRNA, which is beyond
the detection limits of our RT-PCR methods. Even if this is the
case, we readily detect an enrichment of up to 1,000-fold for
cyclin D1 relative to GAPDH mRNAs despite the relative dif-
ferences in abundance, with GAPDH being the much more
abundant mRNA in both fractions (Fig. 1 C and see Fig. 3 B).
Thus, using two independent methods, immunoprecipitation
and SNAAP, we demonstrate that eIF4E physically associates
with specific mRNAs in the nuclear fraction. Furthermore,
eIF4E requires its cap-binding activity for this association but
not W73 on the dorsal surface.
Recent findings by another laboratory suggest that eIF4E
associates with all mRNAs in the nuclear fraction (Lejeune et
al., 2002), whereas the data we present here clearly indicate
that eIF4E binds cyclin D1 but not GAPDH or actin mRNAs in
the nuclear fraction. The most likely reason for this discrep-
ancy is differences in experimental approach. One major differ-
ence is that we monitor association of eIF4E with endogenous,
not overexpressed, mRNAs (Fig. 1). Overexpression could lead
to the formation of RNPs that are different from endogenous
RNPs. Thus, we initiated our studies with endogenous eIF4E as
well as endogenous mRNAs. Detection of bound mRNAs in
immunoprecipitated fractions is also critical for optimal inter-
pretation of these experiments. We confirmed our results with
quantitative RT-PCR methods in order to ensure that back-
ground binding of mRNAs was not mistaken for real binding.
Furthermore, we obtain the same results using different eIF4E
antibodies or reconstituting the complexes with eIF4E-GST.
Clearly, our specificity correlates well with previous observa-
tions by our group and the Sonenberg group that eIF4E overex-
pression up-regulates cyclin D1 but not GAPDH or actin
mRNA transport and correspondingly up-regulates cyclin D1
but not GAPDH and actin protein levels.
Figure 1. eIF4E associates with cyclin D1 but not GAPDH mRNA in the
nuclear fraction of U2OS or HEK293T cells. (A) U2OS total cell lysates
were immunoprecipitated (IP) with either an eIF4E antibody or mouse im-
munoglobulin (IgG) as a control. RNAs were detected by RT-PCR as indi-
cated. Tot represents 0.5% of input RNA. (B) U2OS nuclear lysates were
immunoprecipitated using antibodies to eIF4E (mAb eIF4E), PML (mAb
PG-M3), or mouse IgG. RNase A indicates treatment before IP as a nega-
tive control. Total and nuclear (nc) represent 5% of RNA input. (C) U2OS
nuclear lysates were subjected to SNAAP analysis with eIF4EWT- GST
and mutant (W56A and W73A) fusion proteins. GST only was used as a
negative control. Bound RNAs were detected by RT-PCR. Nc represents
the percentage of input as indicated. RT-PCRs for A–C were detected by
ethidium bromide staining. (D) As a control for cap dependence, the abil-
ity to compete for eIF4E binding by addition of 50  M m
7GpppG cap an-
alogue or 50  M GpppG negative control was tested in the nuclear frac-
tion of HEK293T cells. The ability of cyclin D1 and GAPDH mRNA to
immunoprecipitate with eIF4E after treatments as indicated was monitored
by semi-quantitative PCR. (E) Parallel RT-PCR methods to the experiments in
A–C confirm the above results indicating eIF4E selectively binds cyclin D1
in a cap-dependent manner. Relative fold values were as calculated as de-
scribed in the Materials and methods for both cyclin D1 and GAPDH
mRNAs. (F) K562 nuclear lysates were immunoprecipitated using antibod-
ies to eIF4E (mAb eIF4E), CBC (pAb CBP80), or mouse IgG; nc represent
5% of RNA input. (G) Proteins from immunoprecipitations by eIF4E and
CBP antibodies or mouse IgG were analyzed by Western blot (WB).
White line indicates that intervening lanes have been spliced out. 
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Cyclin D1 mRNAs are localized to a 
subset of eIF4E nuclear bodies
 
Because eIF4E specifically associates with cyclin D1 mRNA
in the nucleus, we examined whether cyclin D1 mRNA specifi-
cally associates with eIF4E nuclear bodies. In this way, eIF4E
nuclear bodies could be sites of assembly of specific RNPs or
functional storage sites. Studies were performed in U2OS and
NIH3T3 cells. The localization of cyclin D1 or GAPDH mRNAs
was determined using in situ hybridization and the localization
of eIF4E and another component of the nuclear body, PML,
through immunofluorescence. The results were monitored using
confocal microscopy. Similar results are observed in both U2OS
and NIH3T3 cells (Fig. 2, A and B).
These studies reveal that cyclin D1 mRNAs (red) are found
throughout the cytoplasm and nucleoplasm but are additionally
enriched in bodies in the nucleus. These local sites of enrichment
colocalize with a subset of eIF4E nuclear bodies (green). Sites of
colocalization of eIF4E nuclear bodies and cyclin D1 mRNAs
are shown in yellow with two of several such sites marked with
arrows (Fig. 2). Note that the objective for all experiments in
Fig. 2 was 100
 
  
 
with further magnifications as follows: twofold
for A–C; and 1.5-fold for D. The current resolution of these stud-
ies does not enable us to distinguish whether cyclin D1 mRNAs
are found on the surface or within the eIF4E bodies. Consistent
with previous studies (Lai and Borden, 2000; Cohen et al., 2001),
there are two populations of eIF4E nuclear bodies, those, which
contain PML, and those, which do not. The majority of eIF4E
(green) and PML (blue) colocalize to the same nuclear bodies
(light blue) and, as observed previously for many cells, there are
additional eIF4E bodies (Fig. 2 A, green; Lai and Borden, 2000;
Cohen et al., 2001). Importantly, mRNAs were never observed
to colocalize with PML nuclear bodies consistent with previous
studies showing RNA did not localize with PML nuclear bodies
(Boisvert et al., 2000). Thus, cyclin D1 mRNAs localize to the
subset of eIF4E nuclear bodies that do not contain PML. As ex-
pected, GADPH mRNAs do not localize with either PML or
eIF4E nuclear bodies (Fig. 2 B). These results are consistent with
the observation that nuclear GAPDH mRNAs do not physically
associate with eIF4E and do not have their export modulated by
eIF4E overexpression (Topisirovic et al., 2002, 2003a). As a
negative control, probes for cyclin D1 in situ hybridization in
cyclin D1
 
 
 
/
 
 
 
 cells revealed no signal indicating that these probes
are specific for cyclin D1 (Fig. 2 C). Furthermore, RNase treat-
ment completely abolishes signals (not depicted).
As expected given the above results, immunoprecipita-
tion studies with a PML antibody reveal no association with ei-
ther cyclin D1 or GAPDH mRNAs (Fig. 1 B). These data are
consistent with our previous findings that PML reduces the af-
finity of eIF4E for the m
 
7
 
G cap by 
 
 
 
100-fold (Kentsis et al.,
2001), thus disabling RNA binding. Because eIF4E requires its
Figure 2. Cyclin D1 but not GAPDH mRNAs colocalize
with a subset of eIF4E nuclear bodies. (A) Co-localization
of cyclin D1 mRNA with PML and eIF4E proteins was an-
alyzed in U2OS or NIH3T3 cells. Cyclin D1 mRNA was
detected using in situ hybridization with a digoxigenin
labeled nick-translated probe to cyclin D1 (red). Cells
were then immunostained using an eIF4E mAb conju-
gated directly to FITC (green) and PML mAb 5E10 (blue).
(B) The same as in A, except digoxigenin nick-translated
probes to GAPDH were used for in situ hybridization.
Within these panels, different combinations of overlays
of the same micrographs are shown to highlight the local-
ization of cyclin D1 mRNAs with eIF4E nuclear bodies
(see arrows). (C) In situ hybridization for cyclin D1 mRNAs
and immunostaining for eIF4E protein in cyclin D1
 / 
cells was performed as described above. (D) HEK293T
cells contain eIF4E bodies similar in size, number and
morphology observed for other cell types. Cells were
stained with a pAb to eIF4E (Morley and Pain, 1995).
Staining with mAb eIF4E gave identical results (not de-
picted). For all panels, confocal micrographs represent a
single optical section through the plane of the cell. 
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cap-binding activity for interaction with cyclin D1 (Fig. 1, D
and E), it is consistent that cyclin D1 mRNAs are not found at
PML containing eIF4E nuclear bodies.
In summary, cyclin D1 mRNAs localize to a subset of
eIF4E nuclear bodies. Localization of mRNAs to the bodies is
specific and is likely to be functionally important for their sub-
sequent transport to the cytoplasm. In this way, eIF4E nuclear
bodies may be assembly sites for specific eIF4E-RNPs, which
enable promotion of export to the cytoplasm. Furthermore, it ap-
pears that, in the nucleus, there must be features particular to the
bound mRNAs that impart the observed specificity of eIF4E.
 
Physical association of eIF4E with 
mRNAs is correlated with enhanced 
mRNA transport
 
Above, we demonstrate that both wild-type eIF4E and the
W73A mutant physically associate with cyclin D1 mRNA in
the nuclear fraction but that the W56A mutant, which is defi-
cient in cap binding, does not (Fig. 1 C). To determine whether
there is a correlation between binding and mRNA transport, we
assessed the ability of these mutants to promote transport of cy-
clin D1 mRNA. Stably transfected NIH3T3 cells expressing
mutant or wild-type proteins were fractionated and mRNAs
monitored by Northern analysis (Fig. 3 A and Table I) as de-
scribed previously (Topisirovic et al., 2002). U6snRNA and
tRNALys serve as fractionation controls. Note that GAPDH is
not altered in any case, as expected. Furthermore, the mutant
proteins are expressed to similar levels (Fig. 3 C) and total lev-
els of cyclin D1 mRNA are not altered by any of the constructs
(Fig. 3 B). Furthermore, the stability of the cyclin D1 transcript
is not affected by eIF4E (Fig. 3 D and Table II).
Importantly, eIF4E and the W73A mutant promote cyclin
D1 mRNA transport where more cyclin D1 transcripts are
clearly visible in the cytoplasmic fractions versus vector con-
trols. Importantly, the W56A mutant does not alter the subcellu-
lar distribution of cyclin D1 mRNA transcripts (Fig. 3 A and
Figure 3. eIF4E enhanced nucleocytoplasmic transport of cyclin D1 RNA. (A) Nuclear (n) and cytoplasmic (c) fractions were isolated from NIH3T3 cells
stably transfected with eIF4E WT, eIF4E mutants (W56A and W73A) or PML and RNAs were detected by Northern blot (NB) as indicated. U6snRNA
(nuclear) and tRNALys (cytoplasmic) were used as markers for the quality of the fractionation. (B) Northern blot analysis of total RNAs isolated from
NIH3T3 cells transfected as described in A. Ethidium bromide stained gels in A and B demonstrate the quality of the isolated RNA. (C) eIF4E enhanced
mRNA transport leads to up-regulated protein levels of corresponding mRNAs. Total cell lysates from NIH3T3 cells transfected as indicated were analyzed
for protein content by Western blot (WB). (D) Semi-quantitative PCR indicates that eIF4E overexpression does not alter cyclin D1 mRNA stability. Act D
indicates hours of actinomycin treatment. Right panel represents decreasing amounts of RNA used in RT-PCR showing that conditions are semi-quantitative.
(E) Mutant and wild-type eIF4E proteins still form nuclear bodies. NIH3T3 cells overexpressing Xpress-tagged eIF4E wild-type or W73A mutant were immu-
nostained with anti-Xpress antibody to detect exogenous eIF4E (red) and or mAb eIF4E directly conjugated to FITC (green) to detect both endogenous and
exogenous protein. The confocal micrograph represents a single optical section through the cell.
 
Table I. 
 
Relative Nc/Cyt ratio of cyclin D1 mRNA in cells transfected 
as indicated (densitometry analysis of Northern blot experiments)
 
a
 
Vector 1.110 
 
 
 
 0.490
WT4E 0.171 
 
 
 
 0.0828
W56A4E 1.194 
 
 
 
 0.365
W73A4E 0.216 
 
 
 
 0.102
PML 4.552 
 
 
 
 0.632
 
a
 
Cyclin D1 mRNA levels were normalized to GAPDH mRNA; 
 
 
 
 value represents
SD from three independent experiments. 
JCB • VOLUME 169 • NUMBER 2 • 2005 250
 
Table I). One of the consequences of eIF4E-dependent mRNA
transport is increased protein levels due to higher concentrations
of these mRNAs in the cytoplasm and thus increased availabil-
ity of these mRNAs to the translational machinery. Consistent
with the above fractionation studies, cyclin D1 protein levels are
elevated in wild-type and W73A mutant experiments but there
is no increase when the W56A mutant is overexpressed. Thus,
the physical association of cyclin D1 mRNA with the nuclear
fraction of eIF4E is strongly correlated with the enhanced trans-
port of cyclin D1 mRNA from the nucleus to the cytoplasm.
PML overexpression leads to the nuclear retention of cy-
clin D1 but not GAPDH mRNAs (Fig. 3 A), as well as reduced
cyclin D1 but not GAPDH or actin protein levels (Fig. 3 C).
This is consistent with the results from immunoprecipitation
and in situ studies, where PML inhibits formation of eIF4E–
cyclin D1 mRNA complexes (Fig. 1 B and Fig. 2 A). Once
again it links the ability of eIF4E to physically interact with
RNAs to the ability to promote mRNA transport.
Previous studies demonstrated that eIF4E could enter the
nucleus by interaction with the 4E transporter protein (4ET;
Dostie et al., 2000). Here, mutation of the dorsal surface (W73A)
impaired association with the 4ET and thus impaired nuclear en-
try (Dostie et al., 2000). Thus, we performed experiments to en-
sure that the W73A mutant still entered the nucleus and formed
nuclear bodies (Fig. 3 E). Using confocal microscopy, we exam-
ined the subcellular distribution of overexpressed eIF4E or the
W73A mutant using the Xpress epitope tag and additionally an
antibody to eIF4E, which recognizes both endogenous and over-
expressed protein. It is clear from the confocal micrographs that
the W73A mutant is readily detectable in the nucleus and associ-
ates with endogenous eIF4E nuclear bodies (Fig. 3 E). Thus, it ap-
pears that when the W73A mutant is overexpressed it uses an al-
ternate route or can overcome the weaker binding to 4ET, gets
transported into the nucleus and associate with nuclear bodies
(Fig. 3 E). Similar studies with the W56A mutant indicated no al-
teration in subcellular distribution as compared with wild type
(not depicted). In addition, wild-type and mutant forms of eIF4E
are expressed to similar levels (Fig. 3 C). eIF4E levels are ex-
pressed to similar levels (Fig. 3 C). Note that the objective was
100
 
 
 
 for these micrographs with a further 1.5-fold magnification.
 
Identification of an RNA structural 
element that mediates eIF4E sensitivity 
in the nuclear compartment
 
To determine if the association of mRNAs with eIF4E in the
nucleus and eIF4E-dependent mRNA transport are mediated
through some specific mRNA sequence, we analyzed 3
 
 
 
 and 5
 
 
 
UTRs from our model mRNA cyclin D1. A series of chimeric
 
Table II. 
 
Relative cyclin D1 mRNA level after actinomycin D treatment 
of cells transfected with eIF4EWT or vector control (measured by
RT-PCR)
 
a
 
Time 4EWT Vector
 
01  
 
 
 
 0.3422 1 
 
 
 
 0.5820
2 h 0.1654 
 
 
 
 0.04 0.1314 
 
 
 
 0.04600
4 h 0.0718 
 
 
 
 0.0120 0.0567 
 
 
 
 0.0108
6 h 0.0199 
 
 
 
 0.0028 0.0218 
 
 
 
 0.0084
 
a
 
Cyclin D1 mRNA levels were normalized to GAPDH mRNA; 
 
 
 
 value represents
SD from three independent experiments.
Figure 4. eIF4E specifically associates with
4E-SE from the 3 UTR of cyclin D1. (A) Sche-
matic representation of chimeric constructs
used in this study. Full 5  and 3 UTR and dif-
ferent parts of 3 UTR of human cyclin D1
mRNA were cloned up- or downstream of
LacZ, respectively. Numbers represent posi-
tion of UTR fragments in cyclin D1 mRNA. (B)
NIH3T3 cells were transiently transfected with
chimeric LacZ constructs containing UTR-LacZ,
LacZ-3 UTR, or LacZ constructs different parts
of cyclin D1 3 UTR. The nuclear fractions of
the transfected cells were immunoprecipitated
with mAb eIF4E or mouse IgG for a control.
LacZ and  -actin were detected by semi-quan-
titative RT-PCR and ethidium bromide staining
(left). Nc indicates the nuclear fraction before
IP and is 5% input of nuclear mRNA. For the
RT-PCR method (right), relative fold enrichment
is shown for the IP eIF4E fraction versus the IP
IgG fraction indicating the enrichment of
LacZ 3 UTR4 in the IP eIF4E. (C) Sequence
alignment of cyclin D1 4E-SE from ClustalW
(Thompson et al., 1994). GenBank/EMBL/
DDBJ accession numbers are: human gi:
16950654, mouse gi: 6680867 and rat gi:
31377522. GenBank/EMBL/DDBJ accession
no. for chicken is from the Ensembl database
is gallus Gallus|5.14792937-14795000
and gi: U40844. 
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constructs were made fusing the coding region of LacZ to the
5
 
 
 
 or 3
 
 
 
UTRs of cyclin D1 (Fig. 4 A). We assessed whether
these sequences were necessary and sufficient to enable chi-
meric mRNAs to associate with endogenous eIF4E in the nu-
cleus and subsequently have their export modulated. Experi-
ments were performed in NIH3T3 and HEK293T cells, which
gave identical results. Note that HEK293T cells form nuclear
bodies similar in size and morphology to those observed for
NIH3T3 cells (Fig. 2 D). Initial semi-quantitative PCR results
were confirmed by quantitative RT-PCR methods using the
standard curves method (Fig. 4 B).
We monitored the ability of the nuclear fraction of eIF4E
to associate with these mRNAs using immunoprecipitation in
conjunction with PCR (Fig. 4 B). Importantly, eIF4E does not
immunoprecipitate with LacZ mRNA, does not immunoprecipi-
tate with Lac Z-cyclin D1 5
 
 
 
UTR chimeric mRNA, but does as-
sociate with chimeric LacZ mRNA that contains the entire 3
 
 
 
UTR of cyclin D1. We made additional chimeric LacZ con-
structs with two different parts of the 3
 
 
 
UTR using an EcoRI site
positioned approximately in the center of 3
 
 
 
UTR of cyclin D1
cDNA, and showed that chimeric RNA that contains first part of
cyclin D1 3
 
 
 
UTR (
 
 
 
3
 
 
 
UTRA) immunoprecipitates with nuclear
eIF4E whereas the second part (
 
 
 
3
 
 
 
UTRB) does not. Analysis
of additional chimeric constructs containing different elements
from the first part of cyclin D1 3
 
 
 
UTR revealed that the 100-bp
sequence from the 3
 
 
 
UTR of cyclin D1 (located 2,471–2,565 bp
in human cyclin D1 cDNA) is necessary and sufficient for asso-
ciation with eIF4E, so we refer to it as an eIF4E
 
-s
 
ensitive ele-
ment (4E-SE). Importantly, this element is the highly conserved
between human, mouse, rat, and chicken sequences (Fig. 4 C).
In fact, the 4E-SEs between humans and chicken are nearly
identical with 94% conservation versus 59% similarity over the
rest of the 3
 
 
 
UTR. The presence of the 4E-SE in mammals and
birds suggests that it is evolutionarily conserved.
To assess if the interaction of chimeric mRNAs with
eIF4E was functional, we examined the effects of eIF4E over-
expression on their export (Fig. 5). mRNA export was moni-
tored using subcellular fractionation in conjunction with semi-
quantitative RT PCR (Fig. 5 A), northern methods (Fig. 5, B–D)
or quantitative RT-PCR (Table III). eIF4E does not modulate
the transport of LacZ or LacZ chimeras that do not contain the
4E-SE (Fig. 5 and Table III), which is consistent with the ob-
servation that eIF4E does not bind these mRNAs (Fig. 4 B).
Note that total mRNA levels determined from the same trans-
fected cells indicated that LacZ mRNAs levels were not modu-
lated (Fig. 6 B) nor were their stability (Fig. 6 C). Thus, there is
a strong correlation with the ability of eIF4E to associate (di-
rectly or indirectly) with the 3
 
 
 
UTRs of these mRNAs and pro-
mote their transport. Increased export of LacZ mRNA, and thus
the higher levels of cytoplasmic mRNAs when the 4E-SE is
present, is correlated with higher levels of LacZ protein (Fig.
6 A). Consistent with our earlier observations, overexpression
of the W56A mutant does not alter transport of either LacZ or
LacZ-4E-SE as compared with wild-type eIF4E nor did the
W56A mutant alter protein production of either LacZ construct
(Fig. 5 D and Fig. 6 A; Table III). Thus, the mRNAs retain
their cap dependence. Furthermore, all of the chimeric con-
structs had similar levels of total mRNA indicating that differ-
ences observed at the protein level were posttranscriptional and
that differences in association with eIF4E and transport were
not due to differences in expression of the constructs (Fig. 6 B).
Importantly, LacZ-4E-SE transport is negatively regulated by
PML (Fig. 6 A), as we observed for endogenous cyclin D1
mRNA (Fig. 3, A–C). Together, these results indicate that both
the 4E-SE and the m
 
7
 
G cap are required for eIF4E to enhance
transport of these mRNAs.
 
The 4E-SE contributes to eIF4E 
mediated oncogenic transformation
 
We extended these studies to establish whether the 4E-SE con-
tributed to the physiological activities of eIF4E and thereby to
assess the functional significance of this RNA element (Fig. 7).
Our previous studies correlated eIF4E-dependent promotion of
cyclin D1 mRNA export with the transformation activities of
eIF4E so we examined the contribution of the 4E-SE to this ac-
tivity. Transformation activity was assessed by monitoring the
number of foci formed upon eIF4E overexpression in a cyclin
D1
 
 
 
/
 
  
 
fibroblast cell line. Note that the distribution of eIF4E
nuclear bodies is not altered in cyclin D1
 
 
 
/
 
  
 
as compared with
other cell types (Fig. 2 C). First, we determined that eIF4E
Figure 5. 4E-SE is sufficient for eIF4E-mediated
mRNA  transport. PolyA RNA purified from
nuclear  (n) and cytoplasmic (c) fractions of
NIH3T3 cells, cotransfected with eIF4E-2Flag
and chimeric LacZ constructs (as indicated),
were analyzed by (A) semi-quantitative RT-PCR
and ethidium bromide staining (left) or (B)
Northern blot (NB). (C and D) Northern blot
analysis of polyA RNA purified from nuclear
(n) and cytoplasmic (c) fractions of HEK293T
cells cotransfected with eIF4E or W56A
eIF4E and chimeric LacZ constructs (as indi-
cated). Corresponding aliquots taken before
polyA RNA purification indicate quality of the
fractionations. 
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transformed cyclin D1
 
 
 
/
 
 
 
 cells relative to vector controls. Re-
introduction of cyclin D1 constructs containing the full-length
3
 
 
 
UTR (cycFull) led to substantially more foci than cells trans-
fected with eIF4E alone (Fig. 7 A). However, eIF4E’s transfor-
mation activity was not augmented by introduction of cyclin
D1 with no 3
 
 UTR (cycTrunc) being the same as eIF4E over-
expressing cells alone. Importantly, introduction of eIF4E and
cyclin D1, with only the 100 nt 4E-SE (cyc4E-SE), trans-
formed cells as well as constructs containing the full-length
3 UTR. Thus, in the context of cyclin D1
 /  cells, the transfor-
mation activity of eIF4E is only increased by reintroduction of
cyclin D1 when the 4E-SE is present.
Consistently, only those cells transfected with cyclin D1-
3 UTR (cycFull) or cyclin D1-4E-SE (cyc4E-SE) showed in-
creased cyclin D1 protein levels in contrast to vector controls
or cells transfected with cyclin D1 with truncated 3 UTR (cyc-
Trunc; Fig. 7 B). Thus, the presence of the 4E-SE is tightly tied
to eIF4E’s ability to export cyclin D1 and subsequently to effi-
ciently transform cells. These effects can be extended to endog-
enous eIF4E. Cells expressing cycFull or cyc4E-SE, even in
the absence of overexpressed eIF4E, produce more cyclin D1
protein than those cells expressing the truncated version of
cyclin D1 (Fig. 7 B). We confirm this is occurring at the
mRNA transport level by fractionation and RT-PCR methods
(Fig. 7 C). We demonstrate that the ratio of nuclear to cytoplas-
mic cyclin D1 mRNA is  250 times greater in those cyclin
D1
 /  cells expressing the cycTrunc construct than those ex-
pressing the cycFull or cyc4E-SE constructs. Thus, the cycTrunc
is not as efficiently transported to the cytoplasm as cycFull
and cyc4E-SE constructs are. Importantly, the distribution of
GAPDH was not altered by any of these constructs (unpub-
lished data). Northern analysis confirmed these findings and in-
dicated that fractionations were clean (unpublished data). Thus,
the presence of the 4E-SE allows more efficient export of cyclin
D1 mRNA using either endogenous or exogenous eIF4E.
Discussion
These studies reveal that eIF4E associates with and regulates
nuclear mRNAs in a fundamentally different manner than cyto-
plasmic mRNAs. Unlike the cytoplasmic fraction of eIF4E
where cap binding is sufficient for its functional interaction
with mRNAs, in the nucleus eIF4E appears to associate with
regulatory factors that restrict its association with mRNA lack-
ing 4E-SEs. Because eIF4E binds the m
7G cap, we hypothesize
that other factors directly bind the 4E-SE in the 3 UTR and
through physical association with eIF4E increase its affinity for
this subset of mRNAs (Fig. 8). An mRNA looping model is an-
other possibility, where eIF4E cap binding is stabilized by di-
rect contact with the 4E-SE, through an unknown mechanism
(Fig. 8). It seems likely that not only cyclin D1 but also many
other mRNAs could be regulated in this way (unpublished
data), especially given that ODC also has its transport regulated
in this manner (Rousseau et al., 1996).
Our studies and recent reports indicate that eIF4E does
not associate with the CBC nor does it associate with unspliced
mRNA (Ishigaki et al., 2001; Lejeune et al., 2002). These studies
Table III. Relative ratio of cytoplasmic versus nuclear LacZ mRNA of 
cells transfected as indicated (measured by RT-PCR)
a
Construct Relative C:N LacZ mRNA ratio
4EWT   LacZ 1   0.082
4EWT   3 UTR4 462.496   38.114
4EWT   3 UTR Full 373.934   30.195
4EWT   3 UTR2/3 0.823   0.069
4EWT   3 UTRB 1.187   0.119
W56A   lacZ 1.159   0.124
W56A   3 UTR4 1.918   0.286
aLacZ mRNA levels were normalized to GAPDH mRNA;   value represents SD
from three independent experiments.
Figure 6. The presence of the 4E-SE correlates
with increased LacZ protein levels. (A) Protein
levels were analyzed by Western blot (WB) of
total cell lysates from HEK293T cells tran-
siently cotransfected with eIF4E-2Flag con-
structs and indicated chimeric LacZ constructs
or PML, eIF4E-2Flag, and chimeric LacZ con-
structs. Note that HEK293T cells have eIF4E
nuclear bodies (Fig. 3 C). (B) Northern blot
(NB) analysis of total RNA from HEK293T
cells  cotransfected as indicated. Note that
none of the total RNA levels are altered by any
of the transfections. (C) Semi-Q PCR analysis
indicates that the presence of the 4E-SE does
not detectably alter LacZ mRNA stability. Act D
indicates hours treated with actinomycin D.
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suggest that the transfer of capped cyclin D1 mRNA transcripts
from the CBC to eIF4E happens after splicing and before cy-
clin D1 mRNA gets exported from the nucleus. Because eIF4E
and CBC do not coimmunoprecipitate or colocalize, this inter-
action is likely transient one. We cannot rule out the possibility
of a completely novel mechanism by which the cap of cyclin
D1 mRNA is protected by some unknown means between leav-
ing the CBC RNP and associating with eIF4E. This is an area
of future investigation.
mRNAs that get exported in an eIF4E-dependent fash-
ion may undergo some alternative, eIF4E-dependent type of
mRNA quality surveillance. Previous studies suggested that the
nuclear fraction of eIF4E might be involved in low level nu-
clear translation as part of mRNA quality surveillance (Iborra
et al., 2001). However, our studies with the W73A mutant indi-
cate that nuclear translation is not required for the observed
transport function because this mutant is active in transport but
not translation, because it cannot bind eIF4G (Sonenberg and
Gingras, 1998; Gingras et al., 1999). Specialized pathways for
transport of growth-promoting mRNAs such is cyclin D1, and
control of this process by factors such as PML, may have
evolved in order to coordinate gene expression with cellular
proliferation.
eIF4E nuclear bodies must be intact in order to act in
mRNA export because their disruption is correlated with a loss
of export activity (Topisirovic et al., 2003a; Kentsis et al.,
2004). Our data suggest that assembly of eIF4E transport RNPs
happens in or around eIF4E bodies. The colocalization of cy-
clin D1 mRNAs with PML-negative eIF4E nuclear bodies sug-
gests that these sites are areas for assembly of specific subtypes
Figure 8. A model for specific mRNA recognition by
eIF4E in the nucleus. The three dimensional structure of
eIF4E is shown (1ej1; Marcotrigiano et al., 1997). Arrows
indicate   -sheets; coils indicate  -helices. The m
7GDP
cap analogue is shown in yellow and the structure is ren-
dered in PREPI (S. Islam and M. Sternberg, Imperial Col-
lege). We propose two possibilities for 4E-SE recognition
in the nucleus, one that eIF4E by itself binds both, cap
and 4E-SE, and the second one where some other factors
mediate 4E-SE sensitivity in the nucleus, as discussed in
the text. For eIF4E found in the cytoplasm, the translation
machinery denotes the remaining portion of eIF4F and as-
sociated factors, for example, PABP, where this general
terminology was used for simplification. The BPs indicates
eIF4E-binding proteins that inhibit translation. PML and
PRH are factors which inhibit eIF4E mediated transport.
Importantly, mRNAs that are sensitive to eIF4E in one
compartment may or may not be sensitive in the other
compartment, as discussed in the text.
Figure 7. The 4E-SE contributes to eIF4E mediated onco-
genic transformation. (A) Cyclin D1
 /  cells were stably
transfected with eIF4E or cotransfected with either the
coding region of cyclin D1 constructs without the 3 UTR
(cycTrunc), the coding region of cyclin D1 with the full-
length 3 UTR (cycFull), and the coding region of cyclin
D1 with only the 100 nt 4E-SE (cyc4E-SE), and analyzed
for anchorage-dependent foci formation assays. Three in-
dependent experiments were preformed in triplicate and
error bars indicate  SD. Number of foci are relative to
vector control, which was set to 100%. (B) Western blot
analysis (WB) of total cell lysates from cyclin D1
 /  cells
stably transfected as indicated, showing increased cyclin
D1 protein level in cells transfected with constructs con-
taining full-length 3 UTR or 4E-SE compared with the trun-
cated form lacking the 3 UTR sequence. (C) Results of
quantitative RT-PCR experiments using endogenous eIF4E
in cyclin D1
 /  cells. The relative ratios of nuclear (N)/
cytoplasmic (C) cyclin D1 mRNA was determined using
RT-PCR with the relative standard curves method. Values
were normalized to CycFull by setting its ratio arbitrarily
to 1. Standard methods were used to propagate SDs
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of RNPs which permit more efficient export of this restricted
subset of mRNAs to the cytoplasm. In this way, expression of
these targeted mRNAs could be modulated quite quickly. It
seems likely that nuclear eIF4E RNPs involved in promotion of
mRNA export are different from those functioning in transla-
tion, because the W73A mutant is still active in transport (Co-
hen et al., 2001; Topisirovic et al., 2003a). Consistently, eIF4E
does not appear to bind eIF4G in the nucleus (McKendrick et
al., 2001) but eIF4G is an integral part of the eIF4E RNP in the
cytoplasm (Sonenberg and Gingras, 1998). Clearly these re-
sults suggest major differences in functionalities of the corre-
sponding nuclear and cytoplasmic eIF4E RNPs.
eIF4E-dependent promotion of mRNA export could pro-
vide an immediate response system by which the cell responds
to stress and/or growth conditions before transcriptional repro-
gramming. We speculate that this process is not limited just to
cyclin D1 mRNA but that other mRNAs involved in growth
regulation could be regulated this way, including ODC (Rous-
seau et al., 1996) and many others (unpublished data). The abil-
ity of eIF4E to promote the export of growth promoting
mRNAs such as cyclin D1 allows it to turn on a cellular growth
promoting program thereby positioning eIF4E as a critical node
in the growth regulatory network. eIF4E regulating proteins,
such as PML (this paper) and nuclear homeodomain proteins
such as PRH, which directly bind eIF4E (Topisirovic et al.,
2003a) are well positioned to act upstream of eIF4E. Although,
this network also includes important regulation of translation by
the eIF4E-binding proteins (4EBPs; Sonenberg and Gingras,
1998), our findings suggest that these transport and translation
networks may not completely overlap. For instance, cyclin D1
mRNA is sensitive to eIF4E at the transport level, but not at the
translation level (Rousseau et al., 1996). In contrast, ODC
mRNA is sensitive to eIF4E at both levels (Rousseau et al.,
1996). ODC mRNA, like cyclin D1 mRNA, contains a 4E-SE
element (unpublished data). PML appears to be a critical nega-
tive regulator of this nuclear network, thereby shutting down
production of a wide variety of growth promoting proteins si-
multaneously and thus, inhibiting eIF4E-mediated growth and
transformation. These activities rely on eIF4E RNA recognition
through both the m
7G cap and the 4E-SE. eIF4E promotion of
export of specific mRNAs represents an exciting new point of
growth regulation in the cell and a novel regulatory pathway
which when dysregulated could contribute to human cancers.
Materials and methods
Constructs
All UTR-LacZ fusion constructs were made in pcDNA3.1LacZ vector (Invi-
trogen) and positioned 5  or 3  of the coding region of LacZ as appropri-
ate. For cloning of cyclin D1 3 UTR, the NotI restriction site was created in
pD1-1 construct (human cyclin D1 gene in pGEM7Zf; Motokura and Ar-
nold, 1993), 150 bp upstream of stop codon by in vitro mutagenesis
(Quickchange kit; Stratagene) and full-length 3 UTR was cloned using NotI
and XbaI downstream of LacZ (referred here as LacZ-3 UTRFull). Frag-
ments containing the first part of cyclin D1 3 UTR were generated using
NotI and EcoRI, and second part of cyclin D1 3 UTR using EcoRI and XbaI
(note that there is EcoRI site at the position 2,824 bp in human cyclin D1
cDNA) and cloned under NotI–XbaI and EcoI–XbaI, downstream of LacZ
(LacZ 3 UTRA and LacZ 3 UTRB). Individual sequences were amplified us-
ing specific primers containing NotI or XbaI restriction sites at their 5 
ends. LacZ 3 UTR2/3 contains segment 2,091–2,459 bp from cyclin D1
mRNA, LacZ 3 UTR 3 contains sequence 2,361–2,459 bp, LacZ3/4
contains segment 2,361–2,565 and LacZ 3 UTR4 contains sequence
2,481–2,565 bp from human cDNA. The 5 UTR was amplified from cy-
clin D1 cDNA (ATCC MGC-2316) and cloned using the HindIII site, up-
stream of AUG codon for Xpress tag. pcDNA2Flag-eIF4E construct was
made by inserting of eIF4E cDNA into the EcoRI–NotI sites (pcDNA2F vec-
tor was gift from Z. Ronai, Burnham Institute, La Jolla, CA). eIF4E mutants
in pcDNA2Flag were made by in vitro mutagenesis (Quickchange kit;
Stratagene). pMV vector, pMV-eIF4E wild type (a gift from N. Sonenberg,
McGill University, Montreal, Quebec, Canada) or mutants, pLINKSV40-
PML and bacterial expression constructs were described previously (Laz-
aris-Karatzas and Sonenberg, 1992; Cohen et al., 2001). Human cyclin
D1 cDNA without the full-length 3 UTR (ATCC MGC-2316) was cloned in
pMV vector using EcoRI and HindIII (cyclin D1 truncated). Cyclin D1 full
construct was made by using HindIII–XbaI fragment from pCDNALacZ-
3 UTR that was blunt ended and cloned under HindIII in pMV-cyclin
D1Trunc (note that there is HindIII site in human cyclin D1 cDNA at posi-
tion 1,206 bp). 4E-SE-4 from cyclin D1 3 UTR was PCR amplified, blunt
ended and cloned under HindIII in pMV-cyclin D1Trunc (cycD14E-SE).
Antibodies and Western analysis
Antibodies used against PML were described previously (a gift from P.
Freemont, Imperial College, London, UK and L. de Jong, University of Am-
sterdam, Amsterdam, Netherlands; Stuurman et al., 1992; Borden et al.,
1995; Topisirovic et al., 2002). Additional antibodies used include mouse
monoclonal anti-eIF4E Ab (BD Transduction Laboratories), polyclonal anti-
eIF4E Ab (a gift from S. Morley, University of Sussex, Brighton, UK; Morley
and Pain, 1995), mouse monoclonal anti–cyclin D1 Ab (BD Biosciences),
mouse monoclonal anti-Xpress Ab (Invitrogen), mouse monoclonal anti-
GAPDH antibody (MAB374; CHEMICON International, Inc.), anti-CBP80
pAb (a gift from L. Maquat, University of Rochester, Rochester, NY; Ishi-
gaki et al., 2001) anti–CBP-20 (a gift from E. Izaurralde, EMBL, Heidel-
berg, Heidelberg, Germany; Izaurralde et al., 1995). Western analysis
was performed as described previously (Topisirovic et al., 2002, 2003a).
Cell culture and transfection
NIH3T3, U2OS, HEK293T, and Nlog (a gift from H. Land, University of
Rochester; cyclin D1
 / ; Perez-Roger et al., 1999) cells were maintained
in 5% CO2 at 37 C in DME (GIBCO BRL; Life Technologies), supple-
mented with 10% FBS, 100 U/ml penicillin, and 100 U/ml streptomycin.
eIF4E and PML stably transfected NIH3T3 were made as described previ-
ously (Topisirovic et al., 2002, 2003a). Transient transfection of NIH3T3
was performed using either GeneJammer Transfection Reagent (Strat-
agene) or Lipofectamine Plus reagent (Invitrogen) according to the manu-
facturer’s instructions. Transient transfections of HEK293T cells were per-
formed using Calcium Phosphate Transfection kit (Invitrogen). Stable
transfections of cyclin D1
 /  cells were performed using Fugene 6 Trans-
fection Reagent (Roche) according to the manufacturer’s instructions. An-
chorage-dependent foci formation assays were conducted as described
previously (Cohen et al., 2001; Topisirovic et al., 2003a).
Immunopurification of eIF4E, isolation of RNA bound to eIF4E and RT-PCR
Nuclei were isolated from 3   10
9 HEK293T cells aliquoted appropri-
ately, as previously described (Topisirovic et al., 2002), resuspended in
ice-cold NET-2 buffer (50 mM Tris-HCL, pH 7.4, 300 mM NaCl, 0.5%
[vol/vol] NP-40, 1  complete protease inhibitors [Roche], 200 U/ml SU-
PERasein [Ambion]) and mechanically disrupted in dounce homogenizer
(type B) on ice. Obtained nuclear extracts were cleared by centrifugation
at 16,000 g for 20 min at 4 C. 1/20 of the supernatant was split in two
and used to obtain nuclear RNA and protein, respectively. 19/20 were
split in three aliquots, two of which, when indicated in the text, were incu-
bated with 50  M m
7GpppG and 50  M GpppG (NEB) in NET-2 buffer
for 30 min at 4 C. Each of aforementioned aliquots was split in two and
immunoprecipitated as described previously (Ishigaki et al., 2001) with
the following modifications: 10  g of anti-eIF4E mouse mAb (Transduction
Laboratories) or 10  g of mouse IgG (Calbiochem) was used per reaction
and after immunoprecipitation, the beads were washed once with NET-2
buffer supplemented with 1 mg/ml of heparin (Sigma-Aldrich). Obtained
RNA was treated with RNase free DNase (Promega) according to the
manufacturer’s instruction. RNA was converted into cDNA using the Sensi-
script Reverse Transcription kit (QIAGEN). RT-PCR was performed in tripli-
cate with the QuantiTect SYBR green RT-PCR Kit (QIAGEN) in Opticon
thermal cycler (MJR). Obtained RT-PCR data was analyzed with Opticon
software (MJR). Primers used for cyclin D1 RT-PCR were cycF, 5 -cagcgag-
cagcagagtccgc-3  and cycR, 5 -acaggagctggtgttccatggc-3 ; and for
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DHR, 5 -tccaccacccgttgctgta. For RT-PCR methods, calculations were done
as described by Applied Biosystems. For semi-quantitative PCR, 30 cycles
were used, and for RT-PCR, standard methods were used. Primers used for
semi-quantitative amplification of GAPDH were the same as for RT-PCR,
and for cyclin D1 and actin amplification the following primers were used:
cycHMF, 5 -cacttcctctccaaaatgcca-3 ; cycHMR, 5 -cctggcgcaggcttgactc-
3 ; ActF, 5 -atctggcaccacaccttctacaatgagctgcg-3 ; and ActR, 5 -cgtcat-
actcctgcttgctgatccacatctgc-3 .
Controls for quality of immunoprecipitation and fractionations
Several steps were taken to ensure that variability between experiments did
not lead to false positive or false negative results. The immunoprecipitated
sample was tested to ensure that eIF4E immunoprecipitated itself and that
IgG did not bind eIF4E as determined by Western blotting. The specificity
of the immunoprecipitation was determined using known positive and nega-
tive controls for eIF4E in the nuclear fraction. Thus, the ability of eIF4E anti-
bodies to immunoprecipitate eIF4E but not CBP80 (Fig. 1 G) or RNA Poly-
merase II was determined (Lai and Borden, 2000). These results are
consistent with the findings from the Maquat and our laboratories where it
was shown that the nuclear fraction of eIF4E does not associate with these
proteins. Furthermore, positive controls for interactions of eIF4E include the
ability to associate with the PML protein (Cohen et al., 2001; Topisirovic et
al., 2003a,b), as have been reported numerous times. In addition, we dem-
onstrate that the transduction laboratory antibody against eIF4E used here
colocalizes with eIF4E antibodies produced in other laboratories (Topi-
sirovic et al., 2004) indicating that the antibody is robust and reliable. Im-
portantly, these experiments ensure that differences in association of various
mRNAs with eIF4E are NOT a result of differences in immunoprecipitation
efficiency or fractionation quality between experiments.
For fractionation controls, the quality of each nuclear and cytoplas-
mic fraction was assessed by monitoring the subcellular distribution of
U6snRNA (nuclear) and tRNA
Lys (cytoplasmic) as we reported previously
and show throughout the text. Additional controls performed for each frac-
tionation include Western analysis of the splicing speckles protein which
served as a nuclear marker (Sc35) and  -actin, which served as a cytoplas-
mic marker (Topisirovic et al., 2003a,b). Additional fraction controls were
done when sufficient material was available (Topisirovic et al., 2003a,b).
SNAAP protocol was performed as described previously (Trifillis et
al., 1999) with the following modifications. Precleared 250  g of nuclear
extracts were added to 50  g of GST-protein beads in 500  l RBB buffer
containing 0.5% NP-40, and after incubation of 30 min at 4 C, 500  g
of yeast tRNA was added per reaction and incubated overnight at 4 C.
All washing of beads was performed in RBB buffer containing 0.25% Tri-
ton X-100 and 0.5% NP-40.
Cellular fractionation and Northern analysis
Fractionation and RNA isolation were described previously (Lai and Bor-
den, 2000; Topisirovic et al., 2002). For LacZ, Poly A RNA was purified
from fractionated RNA using Oligotex mRNA Mini Kit (QIAGEN). Probes
for cyclin D1, GAPDH, U6, and tRNALys for Northern blot analysis were
also previously described (Topisirovic et al., 2002). LacZ probe was
made by PCR amplification using primers LacZF, 5 -cggtcgctaccattaccagtt-
3  and LacZR, 5 -gacgttgtaaaacgacgggat-3 , and labeled using BrightStar
Psoralen-Biotin kit (Ambion).
Immunofluorescence, in situ hybridization, and laser scanning confocal 
microscopy
Immunofluorescence experiments were as described previously (Cohen et
al., 2001; Topisirovic et al., 2002). Fluorescence was observed using
100  optical magnification and 2  digital zoom, unless indicated other-
wise, on an inverted laser scanning confocal microscope (model TCS-SP
(UV); Leica) exciting at 488, 568, or 351/364 nm (at RT). All channels
were detected separately, and no cross talk between the channels was ob-
served. Micrographs represent single sections through the plane of cells
with a thickness of  300 nm. Experiments were repeated three times with
more than 500 cells in each sample. In situ hybridization was performed
according to Spector et al. (1998), using nick-translated DIG-11-dUTP–
labeled (Nick Translation Kit; Roche) cyclin D1 and GAPDH PCR-amplified
fragments (cyclin D1 specific 5SA, 5 -catggaacaccagctcctgt-3  and 3SA,
5 -cgcagccaccacgctccc-3 ; and GAPDH specific GAPDHHF, 5 -acca-
cagtccatgccatcac-3  and GAPDHMR, 5 -tccaccaccctgttgctgggg-3 ) and
detected using anti-DIG Fab fragments (Roche) followed by donkey anti–
sheep Texas red (Jackson ImmunoResearch Laboratories). PML was de-
tected using 5E10 mAb (for U2OS cells) followed by Alexa Fluor 350–
conjugated goat anti–mouse Ab (Molecular Probes) or rabbit polyclonal
anti-PML Ab (for NIH 3T3 cells) followed Alexa Flour 350–conjugated
anti–rabbit Ab (Molecular Probes). eIF4E was detected using FITC-conju-
gated mouse monoclonal anti-eIF4E Ab (BD Transduction Laboratories).
Cells were mounted in Vectashield supplemented with DAPI (Vector Labo-
ratories). Images were obtained using TCS-SP software and displayed us-
ing Adobe Photoshop CS 8.0.
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